BPC-157
Synthetic 15-Amino-Acid Peptide
GI Signaling Models
Repair Pathway Research
Evidence: Preliminary
Research Use Only
Aliases
Body Protection Compound-157; PL 14736; Bepecin
CAS Number
137525-51-0
Molecular Formula
C62H98N16O22
Average Molecular Weight
1419.53 g/mol
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Focus
Gastrointestinal and vascular signaling environments
Chemical Class
Synthetic 15-amino-acid peptide
Validation Notice
Molecular Identity Required. Exact terminal state and salt form must be verified per supplier lot number.
Research Domain
Extracellular Matrix Dynamics / Gastrointestinal Signaling
Molecular Status
Canonical parent peptide: free N-terminus and free C-terminal acid. Salt/counterion state and any source-specific modifications must be documented separately.
Evidence Classification
Preliminary
Mechanistic Targets
The BPC-157 pentadecapeptide is investigated for its potential to interface with gastrointestinal and vascular signaling environments. Experimental models have studied its influence on angiogenic signaling, nitric-oxide biology, and cellular migration pathways. Although multiple signaling pathways have been investigated in experimental models, specific molecular targets and the overall mechanism of action remain incompletely characterized. Preliminary reports suggest research relevance in gastrointestinal signaling and tissue-repair pathways, though these effects remain principally preclinical.
Angiogenic Signaling
Evaluated for potential modulation of vascular endothelial factors and tube formation in nonclinical research models.
Nitric-Oxide Biology
Reported in laboratory models to investigate molecular interactions with nitrogen-based signaling pathways.
Repair Pathway Models
Analyzed for potential downstream signaling in mechanistic tendon, ligament, and gastrointestinal tissue models.
Inquiry Areas
Gastrointestinal Signaling
Investigated for interaction with the gastric mucosal barrier and gut-brain signaling axis in animal models.
Angiogenic Signaling
Studied for modulation of vascular endothelial growth factor (VEGF) pathways in experimental environments.
Nitric Oxide Biology
Reported in preclinical models to potentially influence nitric oxide (NO) synthesis and signaling regulation.
Ligament Research Models
Studied for potential effects on fibroblast migration and collagen synthesis in soft-tissue repair environments.
Inflammatory Signaling
Investigated for theoretical modulation of pro-inflammatory cytokines and upstream signaling cascades.
Cellular Migration
Studied in vitro for potential to influence the movement of repair-oriented cells toward sites of injury.
Biological Evidence: Preliminary / Predominantly Preclinical
Limited human exposure and clinical-study information has been reported, but publicly available evidence is insufficient to establish safety or therapeutic efficacy. Most proposed regenerative, gastrointestinal, musculoskeletal, and systemic effects remain principally preclinical, and biological relevance to human physiology has not been established in controlled clinical settings.
NONCLINICAL CONTEXT: Synthetic pentadecapeptide investigated in modeled research environments. Not for human or veterinary administration. Strictly for scientific research objectives.
Relevant analytical parameters may include: exact sequence,
terminal state,
identity by MS,
HPLC purity,
quantitative net peptide content,
salt state,
counterion content,
residual solvents,
water content,
aggregation,
degradation,
endotoxin & sterility where applicable.
Analytical Parameters
BPC-157 stability depends on molecular form, formulation, temperature, pH, moisture exposure, and other environmental conditions. Available literature and regulatory reviews indicate that peptide stability can vary substantially by formulation and storage condition. Solid-state, lyophilized, and solution-stability findings should not be treated as interchangeable. Where formulation-specific stability data are unavailable, this should be classified as an Evidence Gap.
Nonclinical Research Context
The information provided regarding BPC-157 is for identification and nonclinical research documentation only. BPC-157 is not an FDA-approved drug. Publicly available controlled human evidence remains very limited, and human safety and therapeutic efficacy have not been established. This molecule is studied for potential biological relevance to gastrointestinal and tissue repair signaling pathways in experimental models and is provided strictly for laboratory research use by qualified institutions.